Kimberly-Clark (KMB) Tops Q3 EPS by 7c; Trims Outlook

Kimberly-Clark (NYSE: KMB) reported Q3 EPS of $1.61, $0.07 better than the analyst estimate of $1.54. Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $5.36 billion.

Kimberly-Clark sees FY2014 EPS of $5.93-$6.03, versus prior guidance of $6-$6.15 and the consensus of $6.07.

Chairman and Chief Executive Officer Thomas J. Falk said, "We delivered another very good quarter of results, with solid organic sales growth, significant cost savings and margin improvement, and double-digit growth in adjusted earnings per share. We also made further progress with targeted growth initiatives, launched product innovations and supported our brands with increased advertising spending. We generated strong cash flow and continued to allocate capital in shareholder-friendly ways. I'm encouraged with our execution in a challenging environment. And our full-year guidance is consistent with our previous outlook, adjusting for the spin-off of our health care business."

Falk added, "The restructuring program we are undertaking will make our organization more efficient, allow us to offset the impact of stranded overhead costs from the spin-off and give us additional flexibility to invest for future growth. This effort is further evidence of how we manage our company with financial discipline and our commitment to generate attractive returns to shareholders."

For earnings history and earnings-related data on Kimberly-Clark (KMB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Vivos Therapeutics posts 35% revenue gain but widens net loss